MetroNIDAZOLE 0.0075 mg/MG [Nydamax]
RxNorm 701917
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 701917 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: metroNIDAZOLE 0.0075 mg/MG [Nydamax].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetroNIDAZOLE 0.0075 mg/MG [Nydamax]
(Atom ID: 3736966)
SBDCPrescribable
Semantic Branded Drug Component (SBDC):
Metronidazole 0.0075 mg/MG [Nydamax]
(Atom ID: 12300504)
Patient Education
Metronidazole Topical
Metronidazole is used to treat rosacea (a skin disease that causes redness, flushing, and pimples on the face). Metronidazole is in a class of medications called nitroimidazole antimicrobials. It works by stopping the growth of bacteria.
[Learn More]
* Please review the disclaimer below.